A randomized, double blind, comparative study of vitamin D3 versus placebo in post-stroke rehabilitation patients

A randomized, double blind, comparative study of vitamin D3 versus placebo in post-stroke rehabilitation patients - RCT with vitamin D for post-stroke rehabilitation patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007002

Enrollment

100

Registered

2012-01-02

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Vitamin D3 (2000IU/day) placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Poststroke patients hospitalized for rehabilitation 2. Obtained informed consent 3. 20 years of age or older 4. Rehabilitation doctors judge that patients require inpatient rehabilitation for 3 months.

Exclusion criteria

Exclusion criteria: 1. Taking vitamin D supplement or 1,25 vitamin D, Calcium 2. History of kidney stone and bone fracture 3. Ingestion of vitamin D capsule orally is impossible 4. Independent walking or total assistance on admission 5. Other difficulties judged by the surgeon in charge

Design outcomes

Primary

Measure	Time frame
FIM gain(8 weeks)	—

Secondary

Measure	Time frame
FIM efficiency, Calf circumference(8 weeks), Grip strength(8 weeks), Brunnstrom recovery stage(8 weeks)	—

Countries

Japan

Contacts

Public ContactMitsuyoshi Urashima

The Jikei University School of Medicine Division of Molecular Epidemiology

urashima@jikei.ac.jp03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026